Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy

Archives of Physiology and Biochemistry

Volumn 114, Issue 5, 2008, Pages 340-348

  Rodriguez, Walter E ^a   Tyagi, Neetu ^a   Deng, Alan Y ^b   Adeagbo, Aso ^a   Joshua, Irving G ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

ECM remodelling; Endothelial cardiomyocyte coupling; Heart failure; MMP; TIMP

Indexed keywords

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL; ARTICLE; CONGENIC STRAIN; DAHL SALT SENSITIVE RAT; ECHOGRAPHY; ELECTROCARDIOGRAPHY; ENDOTHELIUM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HYPERTENSION; LEWIS RAT; MALE; METABOLISM; PATHOLOGY; RAT;

ANIMALS; ANIMALS, CONGENIC; ELECTROCARDIOGRAPHY; ENDOTHELIUM; FEMALE; GENE EXPRESSION REGULATION; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; METALLOPROTEASES; MYOCYTES, CARDIAC; RATS; RATS, INBRED DAHL; RATS, INBRED LEW; TISSUE INHIBITOR OF METALLOPROTEINASES;

ANIMALIA; RATTUS;

EID: 57649114732     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450802535978     Document Type: Article

References (27)

1. Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK, et al. 2000. Anti-angiogenic clues from vascular basement membrane collagen. Cancer Res 60(9):2520-26.
2. Cox MJ, Hawkins UA, Hoit BD, Tyagi SC. 2004. Attenuation of oxidative stress and remodelling by cardiac inhibitor of metalloproteinase protein transfer. Circulation 109(17):2123-28.
3. Deng AY. 1998. Is the NOS system involved in genetic hypertension in Dahl rats? Kidney Intern 53:1501-11.
4. Garrett MR, Dene H, Walder R, Zhang Q, Cicila GT, Assadnia S, Deng AY, Rapp JP. 1998. Genomic scan and congenic strains for blood pressure quantitative trait loci using Dahl salt-sentive rats. Genome Res 8:711-23.
5. Henderson BC, Tyagi N, Ovechkin A, Kartha GK, Moshal KS, Tyagi SC. 2007. Oxidative remodelling in pressure overload induced chronic heart failure. Euro J Heart Failure 9(5):450-7.
6. Hunt MJ, Aru GM, Hayden MR, Moore CK, Hoit BD, Tyagi SC. 2002. Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol 283(2): L239-L245, 2002. An editorial on this paper, L237-L238.
7. Julier C, Delepine M, Keavney B, Terwilliger J, Davis S, Weeks DE, Bui T, Jeunemaitre X, Velho G, Froguel P. 1997. Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet 6:2077-86.
8. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R. 2000. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275(2):1209-15.
9. Lindsey MM, Maxwell P, Dunn FG. 2002. TIMP-1: a marker of LV diastolic dysfunction and fibrosis in hypertension. Hypertension 40:136-41.
10. Lominadze D, Roberts AM, Tyagi N, Moshal KS, Tyagi SC. 2006. Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart & Circulatory Physiol 290:H1206-H1213.
11. Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, Kalluri R. 2002. Tumstatin, an endothelial cell specific inhibitor of protein synthesis. Science 295(5552):140-3.
12. Matsui I, Shimosawa T, Uetake Y, Wang H, Ogura S, Kaneko T, Liu J, Ando K, Fujita T. 2006. Protective effect of potassium agonist the hypertensive cardiac dysfunction. Hypertension 48:225-31.
13. Mujumdar VS, Smiley LM, Tyagi SC. 2001. Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Intern J Cardiol 79(2-3):277-86.
14. Mujumdar VS, Tyagi SC. 1999. Temporal Regulation of ECM Components in transition from compensatory hypertrophy to decompensatory heart failure. J Hypertension 17:261-70.
15. O'Reilly MS. 1997. Angiostatin: an endogenous inhibitor of angiogenesis and tumor growth. Exs 79:273-94.
16. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2):277-85.
17. Palijan A, Lambert R, Dutil J, Sivo Z, Deng AY. 2003. Comprehensive congenic coverage revealing multiple blood pressure quantitative trait loci on Dahl rat chromosome 10. Hypertension 42:515-22.
18. Pike SE, Yao L, Jones KD, Cherney B, Appella E, Sakaguchi K, Nakhasi H, Teruya-Feldstein J, Wirth P, Gupta G, et al. 1998. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med 188(12):2349-56.
19. Ramchandran R, Dhanabal M, Volk R, Waterman MJ, Segal M, Lu H, Knebelmann B, Sukhatme VP. 1999. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 255(3):735-9.
20. Rucklidge GJ, Milne G, McGaw BA, Milne E, Robins SP. 1992. Turnover rates of different collagen types measured by isotope ratio mass spectrometery. Biochim Biophys Acta 11:1156-7.
21. Shastry S, Tyagi SC. 2004. Homocysteine induces metalloproteinase and shedding of beta-1 integrin in microvessel endothelial cells. J Cell Biochem 93:207-13.
22. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. 2005. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115(8):2059-64.
23. Tarone RE. 1990. A modified Bonferroni method for discrete data. Biometrics 46:515.
24. Tyagi SC. 1997. Proteinases and myocardial extracellular matrix turnover. Mol Cell Biochem 168:1-12.
25. Tyagi SC. 2000. Physiology of extracellular matrix: Cardiovascular adapation and remodelling. Pathophys 7:177-82.
26. Tyagi SC, Hayden MR. 2003. Role of nitric oxide in matrix remodelling in diabetes and heart failure. Heart Failure Rev 8:23-8.
27. Tyagi SC, Smiley LM, Mujumdar VS. 1999. Homocyst(e)ine impairs endocardial endothelial function. Canad J Physiol & Pharmacol 77:950-7.